Crenessity
Payments companies reported to CMS as associated with Crenessity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Crenessity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Crenessity
These are the largest totals companies reported as associated with Crenessity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alejandro Diaz | Miami, FL | Pediatric Endocrinology | $64,690.03 |
| Gnanagurdasan Prakasam | Sacramento, CA | Pediatric Endocrinology | $55,016.19 |
| Wenyu Huang | Chicago, IL | Endocrinology, Diabetes & Metabolism | $49,126.54 |
| Alan Cohen | Memphis, TN | Endocrinology, Diabetes & Metabolism | $41,278.89 |
| Courtney Finlayson | Chicago, IL | Pediatric Endocrinology | $36,920.30 |
| Jose Gamez-Godoy | Edinburg, TX | Pediatric Endocrinology | $35,940.45 |
| Shrikant Tamhane | Columbus, OH | Endocrinology, Diabetes & Metabolism | $35,288.56 |
| Run Yu | Los Angeles, CA | Endocrinology, Diabetes & Metabolism | $32,361.56 |
| Mary Abuzzahab | Saint Paul, MN | Pediatric Endocrinology | $27,647.37 |
| Kyriakie Sarafoglou | Minneapolis, MN | Pediatrics | $27,616.67 |
Prescribed Crenessity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.